One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study.

Yetgin, T; Boersma, E; Smits, P C; de Vries, A G; Huijskens, E; Zijlstra, F; van der Linden, M M J M; van Geuns, R J M

Yetgin, T; Boersma, E; Smits, P C; de Vries, A G; Huijskens, E; Zijlstra, F; van der Linden, M M J M; van Geuns, R J M.

Afiliación

Yetgin T; Department of Cardiology, Thorax center, Erasmus MC, Rotterdam, The Netherlands.
Boersma E; Department of Cardiology, Thorax center, Erasmus MC, Rotterdam, The Netherlands.
Smits PC; Department of Cardiology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.
de Vries AG; Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.
Huijskens E; Department of Cardiology, Thorax center, Erasmus MC, Rotterdam, The Netherlands.
Zijlstra F; Department of Cardiology, Thorax center, Erasmus MC, Rotterdam, The Netherlands.
van der Linden MMJM; Department of Cardiology, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands. M.vanderLinden3@Franciscus.nl.
van Geuns RJM; Department of Cardiology, Thorax center, Erasmus MC, Rotterdam, The Netherlands.

Neth Heart J ; 26(7-8): 393-400, 2018 Aug.

Article en En | MEDLINE | ID: mdl-29931649

Palabras clave

Acute coronary syndrome; Percutaneous coronary intervention; Prasugrel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Neth Heart J Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google